Skip to content

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
  • Home
  • About
    • NIH Collaboratory
      • Coordinating Center
      • NIH Collaboratory Trials
      • Core Working Groups
      • Steering Committee
      • Distributed Research Network
      • Our Impact
    • Living Textbook
      • Table of Contents
      • How to Use This Site
  • Resources
    • Data and Resource Sharing
    • Training Resources
    • Tools for Researchers
    • Publications
    • Knowledge Repository
  • Webinar
  • Podcast
  • News
    • News Feed
    • Calendar
    • Subscribe
return to home
Subscribe to Newsletter go to twitter feed go to linkedin go to blue sky feed
Search
NIH Collaboratory
Living Textbook of
Pragmatic Clinical Trials

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
home button

Rethinking Clinical Trials

A Living Textbook of Pragmatic Clinical Trials

  • Design
    • What is a Pragmatic Clinical Trial?
    • Decentralized Pragmatic Clinical Trials
    • Developing a Compelling Grant Application
    • Experimental Designs and Randomization Schemes
    • Endpoints and Outcomes
    • Analysis Plan
    • Using Electronic Health Record Data
    • Building Partnerships and Teams to Ensure a Successful Trial
    • Intervention Delivery and Complexity
    • Patient Engagement
  • Data, Tools & Conduct
    • Assessing Feasibility
    • Acquiring Real-World Data
    • Assessing Fitness-for-Use of Real-World Data
    • Study Startup
    • Participant Recruitment
    • Monitoring Intervention Fidelity and Adaptations
    • Patient-Reported Outcomes
    • Clinical Decision Support
    • Mobile Health
    • Electronic Health Records–Based Phenotyping
    • Navigating the Unknown
  • Dissemination & Implementation
    • Data Sharing and Embedded Research
    • Dissemination Approaches for Different Audiences
    • Implementation
    • End-of-Trial Decision-Making
  • Ethics & Regulatory
    • Privacy Considerations
    • Identifying Those Engaged in Research
    • Collateral Findings
    • Consent, Disclosure, and Non-Disclosure
    • Data and Safety Monitoring
    • Ethical Considerations of Data Sharing in Pragmatic Clinical Trials
    • Ethics for AI and ML
    • IRB Responsibilities and Procedures

Responsibilities of Relying Institutions – ARCHIVE

CHAPTER SECTIONS

ARCHIVED PAGE

Archived on September 26, 2025. Go to the latest version.

The Logistics of Using a Single IRB


Section 3

Responsibilities of Relying Institutions – ARCHIVE

Expand Contributors

Pearl O’Rourke, MD
See the Acknowledgments for additional contributors.

Contributing Editor

Damon M. Seils, MA

The relying institution relies on the sIRB for IRB review and approval of the protocol but maintains responsibility for all other institutional requirements, which must be completed and then communicated to the reviewing IRB. The specific institutional responsibilities vary by study based on the nature of the research being conducted. These institutional responsibilities can include:

  • review and approval of local non-IRB institutional committees—often called ancillary reviews—such as, radiation safety, pharmacy, nursing, biosafety, data security;
  • assessment of competency of investigator and staff to conduct the research and review and management of any investigator or institutional conflicts of interest;
  • assessment of adequacy of local resources for conducting the research;
  • identification of local context issues that may affect the conduct of the research that need to be communicated to the reviewing IRB, such as local standards of care, local laws, and characteristics of the local population; and
  • institutional policies, such as the processes for handling noncompliance and assessments of conflict of interest.

In most institutions, the local IRB office or Human Research Protection Program (HRPP) office routinely coordinates and/or documents the myriad institutional reviews. The reviews are usually triggered by submission of a protocol to the local IRB office. In most situations, when an institution cedes IRB review to an external IRB, an application still must be submitted to the local IRB office or HRPP office to initiate and monitor the necessary reviews and sign-offs via a required “local context review.” This means that the site investigator must work with both the sIRB and their own local IRB office or HRPP office.

While the local site review is conducted by the IRB office or HRPP office, this is not a review by an IRB committee and is not designed to assess whether the study meets the criteria for IRB approval. The formal IRB review remains the responsibility of the sIRB.

Previous Section Next Section

SECTIONS

CHAPTER SECTIONS

sections

  1. Introduction- ARCHIVE
  2. Process for Setting Up an sIRB – ARCHIVE
  3. Responsibilities of Relying Institutions – ARCHIVE
  4. Working With an sIRB During the Conduct of Research – ARCHIVE

ACKNOWLEDGMENTS

back to top

Megan K. Singleton, JD, MBE, CIP, reviewed previous versions of this chapter.

back to top


Version History

Published January 18, 2024

current section :

Responsibilities of Relying Institutions – ARCHIVE

  1. Introduction- ARCHIVE
  2. Process for Setting Up an sIRB – ARCHIVE
  3. Responsibilities of Relying Institutions – ARCHIVE
  4. Working With an sIRB During the Conduct of Research – ARCHIVE

Citation:

O’Rourke P. The Logistics of Using a Single IRB: Responsibilities of Relying Institutions – ARCHIVE. In: Rethinking Clinical Trials: A Living Textbook of Pragmatic Clinical Trials. Bethesda, MD: NIH Pragmatic Trials Collaboratory. Available at: https://rethinkingclinicaltrials.org/chapters/ethics-and-regulatory/the-logistics-of-using-a-single-irb/responsibilities-of-relying-institutions/. Updated October 2, 2025. DOI: 10.28929/238.

Footer Menu

  • How to Use This Site
  • About NIH Collaboratory
  • Enrollment Reporting
  • Grand Rounds
  • Funding Statement
Link to Twitter Link to LinkedIn Link to Blue Sky Link to NIH Collaboratory email

Reference in this Web site to any specific commercial products, process, service, manufacturer, or company does not constitute its endorsement or recommendation by the U.S. Government or National Institutes of Health (NIH). NIH is not responsible for the contents of any “off-site” Web page referenced from this server.

Log in
Privacy Statement
WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly. Site Map